Pembrolizumab-induced necrotizing myositis in a patient with metastatic non-small-cell lung cancer: a case report

A 57-year-old man presented with swelling and pain in the lower limbs, inability to walk and increasing dyspnea for 2 days. Because of refractory stage IV non-small-cell lung cancer, pembrolizumab was started 21 days before presentation. Since then, he experienced general discomfort, fatigue and bil...

Descripción completa

Detalles Bibliográficos
Autores principales: Claus, Jonas, Van Den Bergh, Annelies, Verbeek, Sanne, Wauters, Els, Nackaerts, Kristiaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802710/
https://www.ncbi.nlm.nih.gov/pubmed/31645893
http://dx.doi.org/10.2217/lmt-2018-0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802710/
https://www.ncbi.nlm.nih.gov/pubmed/31645893
http://dx.doi.org/10.2217/lmt-2018-0017

Ejemplares similares